nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP2B6—Sorafenib—thyroid cancer	0.126	0.194	CbGbCtD
Modafinil—CYP3A5—Sorafenib—thyroid cancer	0.0991	0.153	CbGbCtD
Modafinil—CYP2C19—Sorafenib—thyroid cancer	0.0799	0.123	CbGbCtD
Modafinil—CYP2B6—Doxorubicin—thyroid cancer	0.0763	0.118	CbGbCtD
Modafinil—CYP1A2—Sorafenib—thyroid cancer	0.0737	0.114	CbGbCtD
Modafinil—CYP2C9—Sorafenib—thyroid cancer	0.0664	0.103	CbGbCtD
Modafinil—CYP3A4—Vandetanib—thyroid cancer	0.0641	0.099	CbGbCtD
Modafinil—CYP3A4—Sorafenib—thyroid cancer	0.0386	0.0597	CbGbCtD
Modafinil—CYP3A4—Doxorubicin—thyroid cancer	0.0234	0.0362	CbGbCtD
Modafinil—Nepafenac—PTGS2—thyroid cancer	0.000973	0.288	CrCbGaD
Modafinil—Oxaprozin—PTGS2—thyroid cancer	0.000808	0.239	CrCbGaD
Modafinil—Photosensitivity—Epirubicin—thyroid cancer	0.000741	0.00212	CcSEcCtD
Modafinil—Pain—Sorafenib—thyroid cancer	0.00074	0.00212	CcSEcCtD
Modafinil—Constipation—Sorafenib—thyroid cancer	0.00074	0.00212	CcSEcCtD
Modafinil—Hypertonia—Doxorubicin—thyroid cancer	0.000727	0.00208	CcSEcCtD
Modafinil—Eczema—Epirubicin—thyroid cancer	0.000724	0.00208	CcSEcCtD
Modafinil—Abnormal vision—Doxorubicin—thyroid cancer	0.000724	0.00207	CcSEcCtD
Modafinil—Eye pain—Epirubicin—thyroid cancer	0.000721	0.00207	CcSEcCtD
Modafinil—Mental disability—Doxorubicin—thyroid cancer	0.00072	0.00206	CcSEcCtD
Modafinil—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000708	0.00203	CcSEcCtD
Modafinil—Increased appetite—Epirubicin—thyroid cancer	0.000693	0.00199	CcSEcCtD
Modafinil—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000689	0.00197	CcSEcCtD
Modafinil—Urticaria—Sorafenib—thyroid cancer	0.000688	0.00197	CcSEcCtD
Modafinil—Photosensitivity—Doxorubicin—thyroid cancer	0.000686	0.00197	CcSEcCtD
Modafinil—Abdominal pain—Sorafenib—thyroid cancer	0.000684	0.00196	CcSEcCtD
Modafinil—Body temperature increased—Sorafenib—thyroid cancer	0.000684	0.00196	CcSEcCtD
Modafinil—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000673	0.00193	CcSEcCtD
Modafinil—Eczema—Doxorubicin—thyroid cancer	0.00067	0.00192	CcSEcCtD
Modafinil—Fenoprofen—PTGS2—thyroid cancer	0.000668	0.198	CrCbGaD
Modafinil—Eye pain—Doxorubicin—thyroid cancer	0.000667	0.00191	CcSEcCtD
Modafinil—Osteoarthritis—Epirubicin—thyroid cancer	0.000651	0.00187	CcSEcCtD
Modafinil—Increased appetite—Doxorubicin—thyroid cancer	0.000641	0.00184	CcSEcCtD
Modafinil—Affect lability—Epirubicin—thyroid cancer	0.000641	0.00184	CcSEcCtD
Modafinil—Migraine—Epirubicin—thyroid cancer	0.000641	0.00184	CcSEcCtD
Modafinil—Hypersensitivity—Sorafenib—thyroid cancer	0.000638	0.00183	CcSEcCtD
Modafinil—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000622	0.00178	CcSEcCtD
Modafinil—Asthenia—Sorafenib—thyroid cancer	0.000621	0.00178	CcSEcCtD
Modafinil—Cardiac arrest—Epirubicin—thyroid cancer	0.000619	0.00177	CcSEcCtD
Modafinil—Mood swings—Epirubicin—thyroid cancer	0.000617	0.00177	CcSEcCtD
Modafinil—Pruritus—Sorafenib—thyroid cancer	0.000613	0.00175	CcSEcCtD
Modafinil—Ataxia—Epirubicin—thyroid cancer	0.000612	0.00175	CcSEcCtD
Modafinil—Osteoarthritis—Doxorubicin—thyroid cancer	0.000602	0.00173	CcSEcCtD
Modafinil—Dry skin—Epirubicin—thyroid cancer	0.000597	0.00171	CcSEcCtD
Modafinil—Abdominal pain upper—Epirubicin—thyroid cancer	0.000595	0.0017	CcSEcCtD
Modafinil—Affect lability—Doxorubicin—thyroid cancer	0.000593	0.0017	CcSEcCtD
Modafinil—Migraine—Doxorubicin—thyroid cancer	0.000593	0.0017	CcSEcCtD
Modafinil—Diarrhoea—Sorafenib—thyroid cancer	0.000592	0.0017	CcSEcCtD
Modafinil—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000586	0.00168	CcSEcCtD
Modafinil—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000586	0.00168	CcSEcCtD
Modafinil—Muscular weakness—Epirubicin—thyroid cancer	0.000574	0.00165	CcSEcCtD
Modafinil—Cardiac arrest—Doxorubicin—thyroid cancer	0.000573	0.00164	CcSEcCtD
Modafinil—Dizziness—Sorafenib—thyroid cancer	0.000573	0.00164	CcSEcCtD
Modafinil—Mood swings—Doxorubicin—thyroid cancer	0.000571	0.00163	CcSEcCtD
Modafinil—Ataxia—Doxorubicin—thyroid cancer	0.000566	0.00162	CcSEcCtD
Modafinil—Asthma—Epirubicin—thyroid cancer	0.000563	0.00161	CcSEcCtD
Modafinil—Influenza—Epirubicin—thyroid cancer	0.000563	0.00161	CcSEcCtD
Modafinil—Eosinophilia—Epirubicin—thyroid cancer	0.000557	0.0016	CcSEcCtD
Modafinil—Dry skin—Doxorubicin—thyroid cancer	0.000552	0.00158	CcSEcCtD
Modafinil—Vomiting—Sorafenib—thyroid cancer	0.000551	0.00158	CcSEcCtD
Modafinil—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00055	0.00158	CcSEcCtD
Modafinil—Rash—Sorafenib—thyroid cancer	0.000546	0.00156	CcSEcCtD
Modafinil—Dermatitis—Sorafenib—thyroid cancer	0.000545	0.00156	CcSEcCtD
Modafinil—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000542	0.00155	CcSEcCtD
Modafinil—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000542	0.00155	CcSEcCtD
Modafinil—Headache—Sorafenib—thyroid cancer	0.000542	0.00155	CcSEcCtD
Modafinil—Bronchitis—Epirubicin—thyroid cancer	0.000541	0.00155	CcSEcCtD
Modafinil—Pancytopenia—Epirubicin—thyroid cancer	0.000534	0.00153	CcSEcCtD
Modafinil—Phenylbutazone—PTGS2—thyroid cancer	0.000534	0.158	CrCbGaD
Modafinil—Muscular weakness—Doxorubicin—thyroid cancer	0.000531	0.00152	CcSEcCtD
Modafinil—Asthma—Doxorubicin—thyroid cancer	0.000521	0.00149	CcSEcCtD
Modafinil—Influenza—Doxorubicin—thyroid cancer	0.000521	0.00149	CcSEcCtD
Modafinil—Pollakiuria—Epirubicin—thyroid cancer	0.00052	0.00149	CcSEcCtD
Modafinil—Eosinophilia—Doxorubicin—thyroid cancer	0.000516	0.00148	CcSEcCtD
Modafinil—Nausea—Sorafenib—thyroid cancer	0.000514	0.00147	CcSEcCtD
Modafinil—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000514	0.00147	CcSEcCtD
Modafinil—Weight increased—Epirubicin—thyroid cancer	0.000512	0.00147	CcSEcCtD
Modafinil—Weight decreased—Epirubicin—thyroid cancer	0.000509	0.00146	CcSEcCtD
Modafinil—Hyperglycaemia—Epirubicin—thyroid cancer	0.000508	0.00145	CcSEcCtD
Modafinil—Pneumonia—Epirubicin—thyroid cancer	0.000505	0.00145	CcSEcCtD
Modafinil—Drowsiness—Epirubicin—thyroid cancer	0.000502	0.00144	CcSEcCtD
Modafinil—Bronchitis—Doxorubicin—thyroid cancer	0.000501	0.00143	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000497	0.00143	CcSEcCtD
Modafinil—Pancytopenia—Doxorubicin—thyroid cancer	0.000494	0.00142	CcSEcCtD
Modafinil—Stomatitis—Epirubicin—thyroid cancer	0.000489	0.0014	CcSEcCtD
Modafinil—Urinary tract infection—Epirubicin—thyroid cancer	0.000488	0.0014	CcSEcCtD
Modafinil—Conjunctivitis—Epirubicin—thyroid cancer	0.000488	0.0014	CcSEcCtD
Modafinil—Sweating—Epirubicin—thyroid cancer	0.000481	0.00138	CcSEcCtD
Modafinil—Pollakiuria—Doxorubicin—thyroid cancer	0.000481	0.00138	CcSEcCtD
Modafinil—Haematuria—Epirubicin—thyroid cancer	0.000478	0.00137	CcSEcCtD
Modafinil—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000475	0.00136	CcSEcCtD
Modafinil—Weight increased—Doxorubicin—thyroid cancer	0.000474	0.00136	CcSEcCtD
Modafinil—Epistaxis—Epirubicin—thyroid cancer	0.000473	0.00136	CcSEcCtD
Modafinil—Weight decreased—Doxorubicin—thyroid cancer	0.000471	0.00135	CcSEcCtD
Modafinil—Sinusitis—Epirubicin—thyroid cancer	0.000471	0.00135	CcSEcCtD
Modafinil—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00047	0.00135	CcSEcCtD
Modafinil—Agranulocytosis—Epirubicin—thyroid cancer	0.000468	0.00134	CcSEcCtD
Modafinil—Pneumonia—Doxorubicin—thyroid cancer	0.000467	0.00134	CcSEcCtD
Modafinil—Drowsiness—Doxorubicin—thyroid cancer	0.000464	0.00133	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00046	0.00132	CcSEcCtD
Modafinil—Bradycardia—Epirubicin—thyroid cancer	0.000459	0.00131	CcSEcCtD
Modafinil—Stomatitis—Doxorubicin—thyroid cancer	0.000453	0.0013	CcSEcCtD
Modafinil—Rhinitis—Epirubicin—thyroid cancer	0.000452	0.00129	CcSEcCtD
Modafinil—Conjunctivitis—Doxorubicin—thyroid cancer	0.000451	0.00129	CcSEcCtD
Modafinil—Urinary tract infection—Doxorubicin—thyroid cancer	0.000451	0.00129	CcSEcCtD
Modafinil—Pharyngitis—Epirubicin—thyroid cancer	0.000447	0.00128	CcSEcCtD
Modafinil—Sweating—Doxorubicin—thyroid cancer	0.000445	0.00128	CcSEcCtD
Modafinil—Urinary tract disorder—Epirubicin—thyroid cancer	0.000445	0.00127	CcSEcCtD
Modafinil—Oedema peripheral—Epirubicin—thyroid cancer	0.000444	0.00127	CcSEcCtD
Modafinil—Haematuria—Doxorubicin—thyroid cancer	0.000443	0.00127	CcSEcCtD
Modafinil—Connective tissue disorder—Epirubicin—thyroid cancer	0.000443	0.00127	CcSEcCtD
Modafinil—Urethral disorder—Epirubicin—thyroid cancer	0.000442	0.00126	CcSEcCtD
Modafinil—Epistaxis—Doxorubicin—thyroid cancer	0.000438	0.00125	CcSEcCtD
Modafinil—Sinusitis—Doxorubicin—thyroid cancer	0.000436	0.00125	CcSEcCtD
Modafinil—Visual impairment—Epirubicin—thyroid cancer	0.000434	0.00124	CcSEcCtD
Modafinil—Agranulocytosis—Doxorubicin—thyroid cancer	0.000433	0.00124	CcSEcCtD
Modafinil—Erythema multiforme—Epirubicin—thyroid cancer	0.000426	0.00122	CcSEcCtD
Modafinil—Bradycardia—Doxorubicin—thyroid cancer	0.000424	0.00122	CcSEcCtD
Modafinil—Cardiac disorder—Epirubicin—thyroid cancer	0.000418	0.0012	CcSEcCtD
Modafinil—Rhinitis—Doxorubicin—thyroid cancer	0.000418	0.0012	CcSEcCtD
Modafinil—Pharyngitis—Doxorubicin—thyroid cancer	0.000414	0.00118	CcSEcCtD
Modafinil—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000412	0.00118	CcSEcCtD
Modafinil—Oedema peripheral—Doxorubicin—thyroid cancer	0.000411	0.00118	CcSEcCtD
Modafinil—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00041	0.00117	CcSEcCtD
Modafinil—Angiopathy—Epirubicin—thyroid cancer	0.000409	0.00117	CcSEcCtD
Modafinil—Urethral disorder—Doxorubicin—thyroid cancer	0.000409	0.00117	CcSEcCtD
Modafinil—Immune system disorder—Epirubicin—thyroid cancer	0.000407	0.00117	CcSEcCtD
Modafinil—Mediastinal disorder—Epirubicin—thyroid cancer	0.000406	0.00116	CcSEcCtD
Modafinil—Chills—Epirubicin—thyroid cancer	0.000404	0.00116	CcSEcCtD
Modafinil—Arrhythmia—Epirubicin—thyroid cancer	0.000402	0.00115	CcSEcCtD
Modafinil—Visual impairment—Doxorubicin—thyroid cancer	0.000402	0.00115	CcSEcCtD
Modafinil—Mental disorder—Epirubicin—thyroid cancer	0.000395	0.00113	CcSEcCtD
Modafinil—Ketoprofen—PTGS2—thyroid cancer	0.000394	0.117	CrCbGaD
Modafinil—Erythema multiforme—Doxorubicin—thyroid cancer	0.000394	0.00113	CcSEcCtD
Modafinil—Malnutrition—Epirubicin—thyroid cancer	0.000392	0.00112	CcSEcCtD
Modafinil—Cardiac disorder—Doxorubicin—thyroid cancer	0.000387	0.00111	CcSEcCtD
Modafinil—Flatulence—Epirubicin—thyroid cancer	0.000386	0.00111	CcSEcCtD
Modafinil—Tension—Epirubicin—thyroid cancer	0.000385	0.0011	CcSEcCtD
Modafinil—Dysgeusia—Epirubicin—thyroid cancer	0.000384	0.0011	CcSEcCtD
Modafinil—Nervousness—Epirubicin—thyroid cancer	0.000381	0.00109	CcSEcCtD
Modafinil—Back pain—Epirubicin—thyroid cancer	0.000379	0.00109	CcSEcCtD
Modafinil—Angiopathy—Doxorubicin—thyroid cancer	0.000378	0.00108	CcSEcCtD
Modafinil—Muscle spasms—Epirubicin—thyroid cancer	0.000377	0.00108	CcSEcCtD
Modafinil—Immune system disorder—Doxorubicin—thyroid cancer	0.000376	0.00108	CcSEcCtD
Modafinil—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000376	0.00108	CcSEcCtD
Modafinil—Chills—Doxorubicin—thyroid cancer	0.000374	0.00107	CcSEcCtD
Modafinil—Arrhythmia—Doxorubicin—thyroid cancer	0.000372	0.00107	CcSEcCtD
Modafinil—Mental disorder—Doxorubicin—thyroid cancer	0.000365	0.00105	CcSEcCtD
Modafinil—Ill-defined disorder—Epirubicin—thyroid cancer	0.000364	0.00104	CcSEcCtD
Modafinil—Malnutrition—Doxorubicin—thyroid cancer	0.000363	0.00104	CcSEcCtD
Modafinil—Anaemia—Epirubicin—thyroid cancer	0.000362	0.00104	CcSEcCtD
Modafinil—Agitation—Epirubicin—thyroid cancer	0.00036	0.00103	CcSEcCtD
Modafinil—Flatulence—Doxorubicin—thyroid cancer	0.000357	0.00102	CcSEcCtD
Modafinil—Tension—Doxorubicin—thyroid cancer	0.000356	0.00102	CcSEcCtD
Modafinil—Dysgeusia—Doxorubicin—thyroid cancer	0.000355	0.00102	CcSEcCtD
Modafinil—Malaise—Epirubicin—thyroid cancer	0.000354	0.00101	CcSEcCtD
Modafinil—Nervousness—Doxorubicin—thyroid cancer	0.000352	0.00101	CcSEcCtD
Modafinil—Vertigo—Epirubicin—thyroid cancer	0.000352	0.00101	CcSEcCtD
Modafinil—Syncope—Epirubicin—thyroid cancer	0.000352	0.00101	CcSEcCtD
Modafinil—Back pain—Doxorubicin—thyroid cancer	0.000351	0.00101	CcSEcCtD
Modafinil—Muscle spasms—Doxorubicin—thyroid cancer	0.000349	0.000999	CcSEcCtD
Modafinil—Palpitations—Epirubicin—thyroid cancer	0.000346	0.000993	CcSEcCtD
Modafinil—Loss of consciousness—Epirubicin—thyroid cancer	0.000345	0.000987	CcSEcCtD
Modafinil—Cough—Epirubicin—thyroid cancer	0.000342	0.00098	CcSEcCtD
Modafinil—Convulsion—Epirubicin—thyroid cancer	0.00034	0.000973	CcSEcCtD
Modafinil—Hypertension—Epirubicin—thyroid cancer	0.000339	0.00097	CcSEcCtD
Modafinil—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000337	0.000964	CcSEcCtD
Modafinil—Anaemia—Doxorubicin—thyroid cancer	0.000335	0.000961	CcSEcCtD
Modafinil—Myalgia—Epirubicin—thyroid cancer	0.000334	0.000956	CcSEcCtD
Modafinil—Chest pain—Epirubicin—thyroid cancer	0.000334	0.000956	CcSEcCtD
Modafinil—Arthralgia—Epirubicin—thyroid cancer	0.000334	0.000956	CcSEcCtD
Modafinil—Agitation—Doxorubicin—thyroid cancer	0.000333	0.000955	CcSEcCtD
Modafinil—Anxiety—Epirubicin—thyroid cancer	0.000333	0.000953	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000332	0.00095	CcSEcCtD
Modafinil—Discomfort—Epirubicin—thyroid cancer	0.00033	0.000945	CcSEcCtD
Modafinil—Malaise—Doxorubicin—thyroid cancer	0.000327	0.000937	CcSEcCtD
Modafinil—Dry mouth—Epirubicin—thyroid cancer	0.000326	0.000935	CcSEcCtD
Modafinil—Vertigo—Doxorubicin—thyroid cancer	0.000326	0.000934	CcSEcCtD
Modafinil—Syncope—Doxorubicin—thyroid cancer	0.000325	0.000932	CcSEcCtD
Modafinil—Confusional state—Epirubicin—thyroid cancer	0.000323	0.000924	CcSEcCtD
Modafinil—Palpitations—Doxorubicin—thyroid cancer	0.000321	0.000918	CcSEcCtD
Modafinil—Anaphylactic shock—Epirubicin—thyroid cancer	0.00032	0.000917	CcSEcCtD
Modafinil—Oedema—Epirubicin—thyroid cancer	0.00032	0.000917	CcSEcCtD
Modafinil—Loss of consciousness—Doxorubicin—thyroid cancer	0.000319	0.000913	CcSEcCtD
Modafinil—Infection—Epirubicin—thyroid cancer	0.000318	0.000911	CcSEcCtD
Modafinil—Cough—Doxorubicin—thyroid cancer	0.000317	0.000907	CcSEcCtD
Modafinil—Shock—Epirubicin—thyroid cancer	0.000315	0.000902	CcSEcCtD
Modafinil—Convulsion—Doxorubicin—thyroid cancer	0.000314	0.0009	CcSEcCtD
Modafinil—Nervous system disorder—Epirubicin—thyroid cancer	0.000314	0.000899	CcSEcCtD
Modafinil—Hypertension—Doxorubicin—thyroid cancer	0.000313	0.000897	CcSEcCtD
Modafinil—Tachycardia—Epirubicin—thyroid cancer	0.000312	0.000895	CcSEcCtD
Modafinil—Skin disorder—Epirubicin—thyroid cancer	0.000311	0.00089	CcSEcCtD
Modafinil—Hyperhidrosis—Epirubicin—thyroid cancer	0.000309	0.000886	CcSEcCtD
Modafinil—Chest pain—Doxorubicin—thyroid cancer	0.000309	0.000885	CcSEcCtD
Modafinil—Myalgia—Doxorubicin—thyroid cancer	0.000309	0.000885	CcSEcCtD
Modafinil—Arthralgia—Doxorubicin—thyroid cancer	0.000309	0.000885	CcSEcCtD
Modafinil—Anxiety—Doxorubicin—thyroid cancer	0.000308	0.000882	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000307	0.000879	CcSEcCtD
Modafinil—Discomfort—Doxorubicin—thyroid cancer	0.000305	0.000874	CcSEcCtD
Modafinil—Anorexia—Epirubicin—thyroid cancer	0.000305	0.000874	CcSEcCtD
Modafinil—Dry mouth—Doxorubicin—thyroid cancer	0.000302	0.000865	CcSEcCtD
Modafinil—Hypotension—Epirubicin—thyroid cancer	0.000299	0.000857	CcSEcCtD
Modafinil—Confusional state—Doxorubicin—thyroid cancer	0.000299	0.000855	CcSEcCtD
Modafinil—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000296	0.000848	CcSEcCtD
Modafinil—Oedema—Doxorubicin—thyroid cancer	0.000296	0.000848	CcSEcCtD
Modafinil—Infection—Doxorubicin—thyroid cancer	0.000294	0.000843	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000292	0.000835	CcSEcCtD
Modafinil—Shock—Doxorubicin—thyroid cancer	0.000291	0.000835	CcSEcCtD
Modafinil—Nervous system disorder—Doxorubicin—thyroid cancer	0.00029	0.000832	CcSEcCtD
Modafinil—Insomnia—Epirubicin—thyroid cancer	0.000289	0.000829	CcSEcCtD
Modafinil—Tachycardia—Doxorubicin—thyroid cancer	0.000289	0.000828	CcSEcCtD
Modafinil—Skin disorder—Doxorubicin—thyroid cancer	0.000288	0.000824	CcSEcCtD
Modafinil—Paraesthesia—Epirubicin—thyroid cancer	0.000287	0.000823	CcSEcCtD
Modafinil—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000286	0.00082	CcSEcCtD
Modafinil—Dyspnoea—Epirubicin—thyroid cancer	0.000285	0.000817	CcSEcCtD
Modafinil—Somnolence—Epirubicin—thyroid cancer	0.000284	0.000815	CcSEcCtD
Modafinil—Anorexia—Doxorubicin—thyroid cancer	0.000282	0.000809	CcSEcCtD
Modafinil—Dyspepsia—Epirubicin—thyroid cancer	0.000282	0.000807	CcSEcCtD
Modafinil—Decreased appetite—Epirubicin—thyroid cancer	0.000278	0.000797	CcSEcCtD
Modafinil—Hypotension—Doxorubicin—thyroid cancer	0.000277	0.000793	CcSEcCtD
Modafinil—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000276	0.000791	CcSEcCtD
Modafinil—Fatigue—Epirubicin—thyroid cancer	0.000276	0.00079	CcSEcCtD
Modafinil—Pain—Epirubicin—thyroid cancer	0.000274	0.000784	CcSEcCtD
Modafinil—Constipation—Epirubicin—thyroid cancer	0.000274	0.000784	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00027	0.000773	CcSEcCtD
Modafinil—Insomnia—Doxorubicin—thyroid cancer	0.000268	0.000767	CcSEcCtD
Modafinil—Paraesthesia—Doxorubicin—thyroid cancer	0.000266	0.000762	CcSEcCtD
Modafinil—Dyspnoea—Doxorubicin—thyroid cancer	0.000264	0.000756	CcSEcCtD
Modafinil—Feeling abnormal—Epirubicin—thyroid cancer	0.000264	0.000755	CcSEcCtD
Modafinil—Somnolence—Doxorubicin—thyroid cancer	0.000263	0.000754	CcSEcCtD
Modafinil—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000262	0.00075	CcSEcCtD
Modafinil—Dyspepsia—Doxorubicin—thyroid cancer	0.000261	0.000747	CcSEcCtD
Modafinil—Decreased appetite—Doxorubicin—thyroid cancer	0.000257	0.000737	CcSEcCtD
Modafinil—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000256	0.000732	CcSEcCtD
Modafinil—Fatigue—Doxorubicin—thyroid cancer	0.000255	0.000731	CcSEcCtD
Modafinil—Urticaria—Epirubicin—thyroid cancer	0.000254	0.000728	CcSEcCtD
Modafinil—Constipation—Doxorubicin—thyroid cancer	0.000253	0.000725	CcSEcCtD
Modafinil—Pain—Doxorubicin—thyroid cancer	0.000253	0.000725	CcSEcCtD
Modafinil—Body temperature increased—Epirubicin—thyroid cancer	0.000253	0.000725	CcSEcCtD
Modafinil—Abdominal pain—Epirubicin—thyroid cancer	0.000253	0.000725	CcSEcCtD
Modafinil—Feeling abnormal—Doxorubicin—thyroid cancer	0.000244	0.000699	CcSEcCtD
Modafinil—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000242	0.000694	CcSEcCtD
Modafinil—Hypersensitivity—Epirubicin—thyroid cancer	0.000236	0.000675	CcSEcCtD
Modafinil—Urticaria—Doxorubicin—thyroid cancer	0.000235	0.000674	CcSEcCtD
Modafinil—Abdominal pain—Doxorubicin—thyroid cancer	0.000234	0.000671	CcSEcCtD
Modafinil—Body temperature increased—Doxorubicin—thyroid cancer	0.000234	0.000671	CcSEcCtD
Modafinil—Asthenia—Epirubicin—thyroid cancer	0.00023	0.000658	CcSEcCtD
Modafinil—Pruritus—Epirubicin—thyroid cancer	0.000226	0.000649	CcSEcCtD
Modafinil—Diarrhoea—Epirubicin—thyroid cancer	0.000219	0.000627	CcSEcCtD
Modafinil—Hypersensitivity—Doxorubicin—thyroid cancer	0.000218	0.000625	CcSEcCtD
Modafinil—Asthenia—Doxorubicin—thyroid cancer	0.000212	0.000609	CcSEcCtD
Modafinil—Dizziness—Epirubicin—thyroid cancer	0.000212	0.000606	CcSEcCtD
Modafinil—Pruritus—Doxorubicin—thyroid cancer	0.000209	0.0006	CcSEcCtD
Modafinil—Vomiting—Epirubicin—thyroid cancer	0.000203	0.000583	CcSEcCtD
Modafinil—Diarrhoea—Doxorubicin—thyroid cancer	0.000203	0.00058	CcSEcCtD
Modafinil—Rash—Epirubicin—thyroid cancer	0.000202	0.000578	CcSEcCtD
Modafinil—Dermatitis—Epirubicin—thyroid cancer	0.000202	0.000577	CcSEcCtD
Modafinil—Headache—Epirubicin—thyroid cancer	0.0002	0.000574	CcSEcCtD
Modafinil—Dizziness—Doxorubicin—thyroid cancer	0.000196	0.000561	CcSEcCtD
Modafinil—Nausea—Epirubicin—thyroid cancer	0.00019	0.000545	CcSEcCtD
Modafinil—Vomiting—Doxorubicin—thyroid cancer	0.000188	0.000539	CcSEcCtD
Modafinil—Rash—Doxorubicin—thyroid cancer	0.000187	0.000535	CcSEcCtD
Modafinil—Dermatitis—Doxorubicin—thyroid cancer	0.000187	0.000534	CcSEcCtD
Modafinil—Headache—Doxorubicin—thyroid cancer	0.000185	0.000531	CcSEcCtD
Modafinil—Nausea—Doxorubicin—thyroid cancer	0.000176	0.000504	CcSEcCtD
